The Role of Microglia in Modulating Neuroinflammation After Spinal Cord Injury

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2021 Sep 28

PMID 34575871

Citations 40

Authors

Sydney Brockie

James Hong

Michael G Fehlings

Affiliations

Soon will be listed here.

Abstract

The pathobiology of traumatic and nontraumatic spinal cord injury (SCI), including degenerative myelopathy, is influenced by neuroinflammation. The neuroinflammatory response is initiated by a multitude of injury signals emanating from necrotic and apoptotic cells at the lesion site, recruiting local and infiltrating immune cells that modulate inflammatory cascades to aid in the protection of the lesion site and encourage regenerative processes. While peripheral immune cells are involved, microglia, the resident immune cells of the central nervous system (CNS), are known to play a central role in modulating this response. Microglia are armed with numerous cell surface receptors that interact with neurons, astrocytes, infiltrating monocytes, and endothelial cells to facilitate a dynamic, multi-faceted injury response. While their origin and essential nature are understood, their mechanisms of action and spatial and temporal profiles warrant extensive additional research. In this review, we describe the role of microglia and the cellular network in SCI, discuss tools for their investigation, outline their spatiotemporal profile, and propose translationally-relevant therapeutic targets to modulate neuroinflammation in the setting of SCI.

Citing Articles

A cryo-shocked M2 macrophages based treatment strategy promoting repair of spinal cord injury via immunomodulation and axonal regeneration effects.

Lu E, Zhou K, Miao J, Zhu Y, Tang J, Du S J Nanobiotechnology. 2025; 23(1):8.

PMID: 39757205 PMC: 11702283. DOI: 10.1186/s12951-024-03018-x.

Regulation of dynamic spatiotemporal inflammation by nanomaterials in spinal cord injury.

Liu Z, Xiang C, Zhao X, Aizawa T, Niu R, Zhao J J Nanobiotechnology. 2024; 22(1):767.

PMID: 39696584 PMC: 11657436. DOI: 10.1186/s12951-024-03037-8.

Can minor trauma cause asymptomatic cervical spinal cord compression leading to severe cervical spinal cord injury in rats?.

Xu L, Wang T, Cao Z, Gao Y, Jiang G, Ma Y Neuroreport. 2024; 36(1):1-10.

PMID: 39514261 PMC: 11661568. DOI: 10.1097/WNR.0000000000002113.

Transcriptomic Profiling of Primary Microglia: Effects of miR-19a-3p and miR-19b-3p on Microglia Activation.

Sahebdel F, Zia A, Quinta H, Morse L, Olson J, Battaglino R Int J Mol Sci. 2024; 25(19).

PMID: 39408930 PMC: 11477266. DOI: 10.3390/ijms251910601.

High mobility group box-1 protein promotes astrocytic CCL5 production through the MAPK/NF-κB pathway following spinal cord injury.

Chi G, Lu J, He T, Wang Y, Zhou X, Zhang Y Sci Rep. 2024; 14(1):22344.

PMID: 39333662 PMC: 11437233. DOI: 10.1038/s41598-024-72947-2.

References

Fehlings M, Tetreault L, Riew K, Middleton J, Aarabi B, Arnold P . A Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy: Recommendations for Patients With Mild, Moderate, and Severe Disease and Nonmyelopathic Patients With Evidence of Cord Compression. Global Spine J. 2017; 7(3 Suppl):70S-83S. PMC: 5684840. DOI: 10.1177/2192568217701914. View

Cronin M, Anderson P, Cook J, Green C, Becker D . Blocking connexin43 expression reduces inflammation and improves functional recovery after spinal cord injury. Mol Cell Neurosci. 2008; 39(2):152-60. DOI: 10.1016/j.mcn.2008.06.005. View

Zhou X, Wahane S, Friedl M, Kluge M, Friedel C, Avrampou K . Microglia and macrophages promote corralling, wound compaction and recovery after spinal cord injury via Plexin-B2. Nat Neurosci. 2020; 23(3):337-350. PMC: 7412870. DOI: 10.1038/s41593-020-0597-7. View

Bennett M, Bennett F, Liddelow S, Ajami B, Zamanian J, Fernhoff N . New tools for studying microglia in the mouse and human CNS. Proc Natl Acad Sci U S A. 2016; 113(12):E1738-46. PMC: 4812770. DOI: 10.1073/pnas.1525528113. View

Aloisi F . Immune function of microglia. Glia. 2001; 36(2):165-79. DOI: 10.1002/glia.1106. View

McKinsey G, Lizama C, Keown-Lang A, Niu A, Santander N, Larpthaveesarp A . A new genetic strategy for targeting microglia in development and disease. Elife. 2020; 9. PMC: 7375817. DOI: 10.7554/eLife.54590. View

Sofroniew M, Vinters H . Astrocytes: biology and pathology. Acta Neuropathol. 2009; 119(1):7-35. PMC: 2799634. DOI: 10.1007/s00401-009-0619-8. View

Lee S, Shi X, Fan A, West B, Zhang J . Targeting macrophage and microglia activation with colony stimulating factor 1 receptor inhibitor is an effective strategy to treat injury-triggered neuropathic pain. Mol Pain. 2018; 14:1744806918764979. PMC: 5858622. DOI: 10.1177/1744806918764979. View

Soriano S, Amaravadi L, Wang Y, Zhou H, Yu G, Tonra J . Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J Neuroimmunol. 2002; 125(1-2):59-65. DOI: 10.1016/s0165-5728(02)00033-4. View

10.

Liddelow S, Marsh S, Stevens B . Microglia and Astrocytes in Disease: Dynamic Duo or Partners in Crime?. Trends Immunol. 2020; 41(9):820-835. DOI: 10.1016/j.it.2020.07.006. View

11.

Lee J, Hamanaka G, Lo E, Arai K . Heterogeneity of microglia and their differential roles in white matter pathology. CNS Neurosci Ther. 2019; 25(12):1290-1298. PMC: 6887901. DOI: 10.1111/cns.13266. View

12.

Halder S, Milner R . Mild hypoxia triggers transient blood-brain barrier disruption: a fundamental protective role for microglia. Acta Neuropathol Commun. 2020; 8(1):175. PMC: 7592567. DOI: 10.1186/s40478-020-01051-z. View

13.

Erblich B, Zhu L, Etgen A, Dobrenis K, Pollard J . Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits. PLoS One. 2011; 6(10):e26317. PMC: 3203114. DOI: 10.1371/journal.pone.0026317. View

14.

Greenhalgh A, Zarruk J, Healy L, Baskar Jesudasan S, Jhelum P, Salmon C . Peripherally derived macrophages modulate microglial function to reduce inflammation after CNS injury. PLoS Biol. 2018; 16(10):e2005264. PMC: 6205650. DOI: 10.1371/journal.pbio.2005264. View

15.

Matute C, Sanchez-Gomez M, Martinez-Millan L, Miledi R . Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc Natl Acad Sci U S A. 1997; 94(16):8830-5. PMC: 23152. DOI: 10.1073/pnas.94.16.8830. View

16.

Inoue S, Inoue M, Fujimura S, Nishinakamura R . A mouse line expressing Sall1-driven inducible Cre recombinase in the kidney mesenchyme. Genesis. 2010; 48(3):207-12. DOI: 10.1002/dvg.20603. View

17.

Ankeny D, Lucin K, Sanders V, McGaughy V, Popovich P . Spinal cord injury triggers systemic autoimmunity: evidence for chronic B lymphocyte activation and lupus-like autoantibody synthesis. J Neurochem. 2006; 99(4):1073-87. DOI: 10.1111/j.1471-4159.2006.04147.x. View

18.

Liddelow S, Guttenplan K, Clarke L, Bennett F, Bohlen C, Schirmer L . Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017; 541(7638):481-487. PMC: 5404890. DOI: 10.1038/nature21029. View

19.

Umebayashi D, Natsume A, Takeuchi H, Hara M, Nishimura Y, Fukuyama R . Blockade of gap junction hemichannel protects secondary spinal cord injury from activated microglia-mediated glutamate exitoneurotoxicity. J Neurotrauma. 2014; 31(24):1967-74. PMC: 4245850. DOI: 10.1089/neu.2013.3223. View

20.

Hammond T, Dufort C, Dissing-Olesen L, Giera S, Young A, Wysoker A . Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes. Immunity. 2018; 50(1):253-271.e6. PMC: 6655561. DOI: 10.1016/j.immuni.2018.11.004. View